Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMany people searching for a Wegovy 2.4mg click chart assume each audible click represents one dose. That is not correct. The 2.4mg Wegovy pen uses a fixed-dose mechanism — a single press of the injector button delivers the full dose. The number of clicks you hear during that press is not a measure you count or act on; it is simply a feature of the pen's internal mechanism. Understanding this distinction matters, because acting on a miscount could lead to an incomplete or repeated injection. Wegovy (semaglutide) is a prescription-only medicine whose dose is always set by your prescriber, not by counting sounds during administration.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The idea of counting clicks spread through patient forums and social media groups where people shared tips for managing their injections. It is understandable. Clicks are audible and tangible, and when you are learning a new injection technique, any physical cue feels reassuring. The problem is that Novo Nordisk's Wegovy pen was not designed so that a specific click count signals a complete dose. The clicking sound comes from the spring mechanism inside the pen as it drives the plunger, and the number of clicks varies depending on injection speed, injection-site tissue resistance and even how firmly you hold the device.
Relying on click counts can lead to one of two errors: stopping early because you reached an expected number, when the dose counter still shows a remaining amount; or re-injecting because you lost count, which risks delivering more than the prescribed dose. Neither outcome is what your prescriber or Novo Nordisk intended. The NHS medicines guidance for semaglutide is clear that patients should follow the instructions in the leaflet supplied with the medicine, which centres on the dose counter, not auditory cues.
The only correct indicator of a complete dose is the dose counter window returning to zero while you keep the button pressed and the needle in place for at least six seconds. That six-second hold is stated in the Wegovy Patient Information Leaflet and is the figure to follow. Worth knowing before your first injection.
Each Wegovy pen is pre-filled and pre-set to one strength. The 2.4mg pen contains one dose. When the injector button is pressed and the full dose is delivered, the counter moves from the starting number to zero. That zero is your confirmation. Hold the pen in place for at least six seconds after the counter reaches zero, then withdraw the needle slowly.
Reaching 2.4mg does not happen on day one. The licensed titration schedule (described factually in the Wegovy dose guide) begins at 0.25mg for the first month, then moves to 0.5mg, 1.0mg, 1.7mg and finally 2.4mg, with roughly four weeks at each level. The graded approach exists to let your body adjust to the medicine and to reduce the intensity of early gastrointestinal side effects. Each step up is a prescriber decision, not something you manage by counting clicks. If you want a sense of how earlier pens work, the same counter-based confirmation applies at every strength, and if you are currently on the third step of the schedule, our 1mg click chart walks you through what to expect from that pen. The 1.7mg pen guide explains the mechanism at the previous step.
As of 2026, the MHRA has also approved a 7.2mg dose and a dedicated single-dose 7.2mg pen for adults with BMI ≥30. That is the upper end of what is now licensed in the UK. If you are already at the maintenance stage and want a clear visual reference for your injections, the dedicated 2.4mg page covers everything specific to that pen, including what to expect when you use it for the first time.
Wegovy pens are stored in the fridge at 2–8°C. A lot of patients keep the current pen on the fridge door shelf, cool enough, visible, less likely to be forgotten. Once removed from the fridge, the pen can be kept at room temperature for a limited period detailed in the Patient Information Leaflet; never estimate that window, always check the leaflet or your prescriber's advice.
On injection technique: rotate sites between your abdomen, outer thigh and upper arm each week. Consistent rotation reduces the risk of skin changes at the injection site. Inject into a clean, dry area, not into broken skin, bruising or areas that feel firm from previous injections. The needle should be changed for every injection; re-using needles dulls the tip and increases discomfort.
For anyone mid-treatment who has questions about technique or whether a previous injection delivered the full dose, the right route is your prescriber, not another forum thread. If you are at the maintenance dose and want a straightforward breakdown of how many clicks to expect and what they mean, the Wegovy 2.4 click chart sets out that information clearly. And for the broader picture of how semaglutide works as a medicine, the Wegovy treatment overview is a good starting point.
If the dose counter did not reach zero, do not re-inject immediately. The Wegovy Patient Information Leaflet and the NHS semaglutide page both advise contacting your prescriber or pharmacist for guidance on what to do about a missed or incomplete dose before the next scheduled injection. The answer depends on timing, your current dose level and your individual treatment plan, all factors only your prescriber can weigh up properly.
If you are experiencing persistent nausea, vomiting, diarrhoea or other gastrointestinal symptoms after a dose, these are the most commonly reported side effects of semaglutide and often settle after the first few weeks at a new strength. Severe, persistent stomach pain (particularly pain that radiates toward the back) is a signal to seek urgent medical attention, as pancreatitis is a known but infrequent side effect. Report any side effects you are concerned about via the MHRA's Yellow Card scheme, which also accepts reports about suspect or counterfeit products.
If you are thinking about starting Wegovy and want your questions answered before your first pen arrives, check your eligibility with our prescribers, the consultation is free, and a real clinician reads your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.